Short-term progression of maximum intima-media thickness of carotid plaque is associated with future coronary events in patients with coronary artery disease

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 507-512

  Hirano, Mitsumasa ^a   Nakamura, Takamitsu ^a   Kitta, Yoshinobu ^a   Takishima, Isao ^a   Deyama, Juntaro ^a   Kobayashi, Tsuyoshi ^a   Fujioka, Daisuke ^a   Saito, Yukio ^a   Watanabe, Kazuhiro ^a   Watanabe, Yosuke ^a   Kawabata, Ken Ichi ^a   Obata, Jyun Ei ^a   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Carotid artery; Coronary artery disease; Coronary events; Intima media thickness; Prognosis

Indexed keywords

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; ECHOCARDIOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON FATAL MYOCARDIAL INFARCTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

AGED; CAROTID ARTERIES; CORONARY ARTERY DISEASE; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 79953034673     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.014     Document Type: Article

References (30)

1. Rothwell P.M., Villarga R., Gibson R., Donders R.C., Warlow C.P. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000, 355:19-24.
2. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003, 91:3A-6A.
3. Simon A., Megnien J.L., Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010, 30:182-185.
4. Nguyen-Thanh H.T., Benzaquen B.S. Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardiol 2009, 104:1383-1388.
5. Heiss G., Sharrett A.R., Barnes R., et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134:250-256.
6. de Groot E., van Leuven S.I., Duivenvoorden R., et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 2008, 5:280-288.
7. Hodis H.N., Mack W.J., LaBree L., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998, 128:262-269.
8. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999, 340:14-22.
9. Taylor A.J., Kent S.M., Flaherty P.J., et al. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002, 106:2055-2060.
10. Pitt B., Byington R.P., Furberg C.D., et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000, 102:1503-1510.
11. Lonn E., Yusuf S., Dzavik V., et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001, 103:919-925.
12. Wildman R.P., Schott L.L., Brockwell S., Kuller L.H., Sutton-Tyrrell K. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol 2004, 44:579-585.
13. Miller W.L., Hartman K.A., Burritt M.F., et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007, 116:249-257.
14. Kitta Y., Obata J.E., Nakamura T., et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009, 53:323-330.
15. Hernandez T.L., Capell W.H., Wolfe P., Gerard L.A., Eckel R.H. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus. Am J Cardiol 2006, 98:1656-1659.
16. Bertges D.J., Muluk V., Whittle J., et al. Relevance of carotid stenosis progression as a predictor of ischemic neurological outcomes. Arch Intern Med 2003, 163:2285-2289.
17. Lewis R.F., Abrahamowicz M., Côté R., Battista R.N. Predictive power of duplex ultrasonography in asymptomatic carotid disease. Ann Intern Med 1997, 127:13-20.
18. Finn A.V., Kolodgie F.D., Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010, 30:177-181.
19. Adams M.R., Nakagomi A., Keech A., et al. Carotid intimal-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995, 92:2127-2134.
20. Hirano M., Nakamura T., Kitta Y., et al. Assessment of carotid plaque echolucency in addition to plaque size increases the predictive value of carotid ultrasound for coronary events in patients with coronary artery disease and mild carotid atherosclerosis. Atherosclerosis 2010, 211:451-455.
21. Takiuchi S., Kamide K., Miwa Y., et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004, 18:17-23.
22. Spence J.D., Eliasziw M., DiCicco M., et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002, 33:2916-2922.
23. Spence J.D. Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol 2002, 89(4A):10B-15B.
24. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003, 41:159-168.
25. Smith S.C., Blair S.N., Bonow R.O., et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001, 38:1581-1583.
26. The Examination Committee of Criteria for " Obesity Disease" in Japan, Japan Society for the Study of Obesity New criteria for " obesity disease" in Japan. Circ J 2002, 66:987-992.
27. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187. CHD Risk Prediction Group.
28. Kaski J.C., Chester M.R., Chen L., Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. Circulation 1995, 92:2058-2065.
29. Desbien A.M., Chonchol M., Gnahn H., Sander D. Kidney function and progression of carotid intima-media thickness in a community study. Am J Kidney Dis 2008, 51:584-593.
30. Solberg L.A., Eggen D.A. Localization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation 1971, 43:711-724.